MOUNTAIN VIEW, Calif., June 14, 2011 /PRNewswire/ — Hotspur
Technologies, a leading developer of catheter-based technologies
aimed at restoring blood flow for patients with obstructed vessels,
today announced the appointment of Fred Khosravi to the
newly-created position of Chairman of its Board of Directors. Mr.
Khosravi, a Hotspur co-founder and current Director, will continue
to work closely with the other Directors as well as Hotspur’s
President & CEO, Gwen Watanabe, in making the strategic
decisions necessary to ensure continued successful
commercialization of Hotspur’s three FDA-cleared balloon
technologies.
Mr. Khosravi, is a managing member of Incept LLC, the medical
device incubator that helped to found Hotspur, and several other
entrepreneurial endeavors focused on developing and commercializing
novel medical device technologies helping to extend the envelope of
life sciences innovation and patient care. Mr. Khosravi has led his
companies, such as AccessClosure, Sadra Medical, Embolic
Protection, Inc., and Confluent Surgical, to name a few, to
commercial success either independently or through significant
partnerships with multi-national medical device corporations. In
addition to various Board memberships, Mr. Khosravi is currently
President & CEO of Ostial Corporation.
“Hotspur Technologies is entering a compelling stage in its
growth as sales begin on its first three products, the
GPSCath™ Catheter, the IQCath™ Catheter, and the
Keeper™ Catheter. I look forward to working closely with the
Hotspur Board, Ms. Watanabe, and the tremendous team at Hotspur in
their rapid growth while continuing to strengthen their pipeline of
products, all of which they are accomplishing with the requisite
capital efficiency for these demanding times to maintain their
innovative leadership,” stated Mr. Khosravi.
“Adding the Chairman role to our Board will strengthen our
long-term corporate strategies while enabling the Co
‘/>”/>
